Document Detail


A comparison of efficacy of Tołpa Torf Preparation (TTP) in the treatment of cervicitis with or without surgery.
MedLine Citation:
PMID:  8239914     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Tołpa Torf Preparation (TTP) is an immunomodulating drug produced by Torf Corporation, Wrocław and registered for human use in Poland. TTP enhances the process of tissue regeneration. Authors evaluate TTP effectiveness in the treatment of inflammatory states of the cervix, especially cervical erosions and the influence of this preparation of the macroscopic, cytological and bacteriological state of the cervix. TTP was used in 31 patients with the diagnosis of cervical erosion. All patients treated as yet were classified into 3 groups, depending on the treatment of cervical erosion used previously. TTP was administered orally in the dose of 5 mg (in 10 ml of water) daily during 10 days and locally in the form of tampons soaked with 1% TTP solution in the volume of 5 ml also during 10 days. TTP administered this way has beneficial therapeutic effects on the healing of cervical erosion accelerating the process of epithelialization and bringing normalization of the cytological picture. Especially beneficial in the treatment of cervical erosion is combined use of TTP and electrocoagulation or curettage--the healing time can be shortened by half.
Authors:
J Woytoń; M Gabryś; T Bielanów; M Zimmer; J Sokalski; R Geneja; M Zborowski
Related Documents :
19120904 - Endoscopic survey of low-dose-aspirin-induced gastroduodenal mucosal injuries in patien...
17143694 - Meta-analysis of the results of intravenous gamma globulin treatment of coronary artery...
3761104 - Effect of metoclopramide on prolonged intraesophageal ph testing in infants with gastro...
18990434 - Effect of increased aspirin dose after stenting in association with clopidogrel: the fi...
8104044 - Serotonergic (5-ht2) mediation of anxiety-therapeutic effects of serazepine in generali...
9076654 - Fourteen-day oral combination dose toxicity study of cgs 16949 a (aromatase inhibitor) ...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Archivum immunologiae et therapiae experimentalis     Volume:  41     ISSN:  0004-069X     ISO Abbreviation:  Arch. Immunol. Ther. Exp. (Warsz.)     Publication Date:  1993  
Date Detail:
Created Date:  1993-12-06     Completed Date:  1993-12-06     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0114365     Medline TA:  Arch Immunol Ther Exp (Warsz)     Country:  POLAND    
Other Details:
Languages:  eng     Pagination:  99-103     Citation Subset:  IM    
Affiliation:
II Department of Obstetrics, Medical Academy, Wrocław, Poland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adjuvants, Immunologic / therapeutic use*
Amino Acids / therapeutic use*
Carbohydrates / therapeutic use*
Combined Modality Therapy
Drug Combinations
Female
Humans
Humic Substances / therapeutic use*
Interferon Inducers / therapeutic use*
Soil / analysis*
Uronic Acids / therapeutic use*
Uterine Cervicitis / drug therapy*,  surgery
Chemical
Reg. No./Substance:
0/Adjuvants, Immunologic; 0/Amino Acids; 0/Carbohydrates; 0/Drug Combinations; 0/Humic Substances; 0/Interferon Inducers; 0/Soil; 0/Tolpa; 0/Uronic Acids

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A randomised, double-blind study on the efficacy of Tołpa Torf Preparation (TTP) in the treatment o...
Next Document:  Quantitation of human haptoglobin by ELISA system based on streptococcal haptoglobin receptors.